Paper Details

  1. Home
  2. Paper Details

Benefit of Biological Drugs for Quality of Life in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of Clinical Trials.

Author: DudekKrzysztof, Jankowska-PolańskaBeata, TańskiWojciech, Świątoniowska-LoncNatalia

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This study examined the impact of different treatments for ankylosing spondylitis (AS), a chronic inflammatory disease affecting the spine and other parts of the body, on quality of life (QoL). The study found that biological medications, a type of drug that targets the immune system, were significantly better at improving QoL compared to standard treatments or a placebo after four months of treatment. While other aspects of the disease also showed improvements, the study did not find significant differences between treatment types in these areas. These findings suggest that biological medications should be considered a primary treatment option for AS to improve QoL.
Paper Details　
Original Abstract of the Article :
Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease involving the axial skeleton, peripheral joints, and extra-articular manifestations like psoriasis, inflammatory bowel disease, or uveitis. A deterioration of quality of life (QoL) affects the disease management and therapeutic ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/5584_2020_611

データ提供：米国国立医学図書館（NLM）

Biological Drugs for Ankylosing Spondylitis: A Oasis of Hope in the Desert of Chronic Pain

Ankylosing spondylitis (AS), a chronic inflammatory disease that primarily affects the spine, can be a difficult journey, like traversing a vast and unforgiving desert. This study examines the impact of biological drugs, a class of medications that target specific immune pathways, on the quality of life (QoL) of patients with AS. The researchers analyzed data from clinical trials to determine the effectiveness of these drugs in improving the QoL of patients with AS.

Biological Drugs: A Refreshing Oasis in the Desert of AS

The study found that biological drugs significantly improved the QoL of patients with AS, offering a refreshing oasis in the desert of chronic pain. These drugs, like a cool breeze in the desert, helped alleviate symptoms, improve mobility, and enhance overall well-being. The study highlights the potential of biological drugs to improve the quality of life for individuals with AS, offering a path towards a more fulfilling life.

The Desert of AS: Seeking Effective Treatments

The desert of AS can be a challenging landscape, marked by pain, stiffness, and fatigue. This study underscores the importance of seeking appropriate medical care and exploring treatment options, including biological drugs, to manage this condition. By utilizing effective treatments and making lifestyle adjustments, individuals with AS can navigate this desert with greater ease and find moments of respite and joy along the way.

Dr.Camel's Conclusion

The study, like a caravan guide navigating the desert, highlights the potential of biological drugs to improve the quality of life for individuals with AS. This research offers hope for a future where effective treatments can help individuals with AS live fuller and more fulfilling lives, allowing them to embrace the journey with greater strength and resilience.

Date :
  1. Date Completed 2021-11-18
  2. Date Revised 2021-11-18
Further Info :

Pubmed ID

33378002

DOI: Digital Object Identifier

10.1007/5584_2020_611

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.